Advanced searches left 3/3

Carcinoma brain metastasis - ClinicalTrials.gov

Summarized by Plex Scholar
Last Updated: 15 November 2021

* If you want to update the article please login/register

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

This is a phase II study to evaluate the security and effectiveness of the combination of nivolumab with ipilimumab and cabozantinib in patients with neglected brain metastases from RCC up until disease progression or excruciating toxicities or client withdrawal.

Source link: https://clinicaltrials.gov/ct2/show/NCT05048212

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions